Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$3.4000
-0.1300 ( -2.30% ) 631.5K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$3.4000

Previous close


$3.5300

Volume


631.5K

Market cap


$227.77M

Day range


$3.3150 - $3.5280

52 week range


$2.7000 - $19.0500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 2 Dec 06, 2024
4/a Other 1 Dec 04, 2024
8-k 8K-related 124 Dec 04, 2024
4/a Other 1 Dec 04, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 2 Nov 27, 2024
4 Insider transactions 2 Nov 27, 2024
4 Insider transactions 2 Nov 26, 2024
8-k 8K-related 49 Nov 21, 2024
8-k 8K-related 118 Nov 15, 2024

Latest News